NuGen Medical Devices Inc.
NGMD.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 119.30K | 183.00K | 419.60K | 784.30K | 779.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 119.30K | 183.00K | 419.60K | 784.30K | 779.20K |
| Cost of Revenue | 60.50K | 89.10K | 188.90K | 377.30K | 375.10K |
| Gross Profit | 58.80K | 93.80K | 230.60K | 407.00K | 404.10K |
| SG&A Expenses | 2.98M | 2.75M | 2.68M | 3.44M | 3.21M |
| Depreciation & Amortization | 381.60K | 371.70K | 341.20K | 455.20K | 453.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.42M | 3.21M | 3.21M | 4.27M | 4.04M |
| Operating Income | -3.30M | -3.03M | -2.79M | -3.49M | -3.26M |
| Income Before Tax | -7.90M | -5.64M | -1.58M | -2.39M | -1.40M |
| Income Tax Expenses | 34.50K | 37.20K | -400.00 | 10.80K | 7.80K |
| Earnings from Continuing Operations | -7.93 | -5.67 | -1.58 | -2.40 | -1.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.93M | -5.67M | -1.58M | -2.40M | -1.41M |
| EBIT | -3.30M | -3.03M | -2.79M | -3.49M | -3.26M |
| EBITDA | -2.80M | -2.53M | -2.31M | -3.02M | -2.79M |
| EPS Basic | -0.03 | -0.03 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 908.14M | 907.58M | 900.00M | 890.28M | 879.12M |
| Average Diluted Shares Outstanding | 908.14M | 907.58M | 900.00M | 890.28M | 879.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |